 |
|
| Colorado
Allergy and Asthma Centers, P.C.,
has participated in clinical research
evaluating new treatments of asthma
and allergies for adults, adolescents,
and children for over 30 years.
Most of our participating subjects
are patients from our practice. |
What
is clinical research?
Clinical research is the study of
new drugs and/or medical devices
and better ways of using current
medicines which may improve treatment
of a disease. These new products
are developed through the combined
efforts of universities, private
industry, government, and physicians
in medical practice. Participation
in clinical trials by patients and
physicians is an essential part
of the development of new drugs
and medical devices. Several trials
may take place over a period of
time until a new drug or device
is available to our patients by
prescription.
Researching a drug or device from
its discovery to to the time it
comes to market usually takes more
than ten years! New treatments and
medications developed by researchers
are carefully tested; safety for
each and every patient is our primary
concern, and we are guided by strict
U.S. Food and Drug Administration
(FDA) regulations. When new drugs
or devices appear promising in the
treatment of allergy and asthma,
our doctors and study staff will
participate in specific clinical
trials evaluating these products.
[ Clinical Research Brochure ]
|
|
Why
does Colorado Allergy and Asthma
Centers, P.C. consider it important
to participate in Clinical Research?
-
To make
a contribution to medical
progress and advancement
-
To influence
the future of drug availability
and cost for our own and other
patients
-
To stay
at the forefront of knowledge
in our profession and specialty,
to provide the best and most
up-to-date treatment for our
patients
-
To make
available to our patients
otherwise unobtainable medications
-
To enable
patients and medical staff
to gain first-hand knowledge
of promising new drugs and
devices
We are proud
that we have been an important
part of helping to make the following
drugs available to our patients:
| Asthma |
Asthma |
Allergies |
| Ventolin |
Aerobid |
Claritin |
| Intal |
Flovent |
Zyrtec |
| Tilade |
QVAR |
Allegra |
| Vanceril |
Serevent |
Clarinex |
| Beclovent |
Foradil |
Rhinocort |
| Azmacort |
Accolate |
Nasacort |
| Pulmicort |
Singulair |
Flonase |
| Advair |
Xopenex |
Nasonex |
| |
|
Singulair |
|
|
|
|
| |
Why
should I participate?
The individuals who participate
in clinical research at Colorado
Allergy and Asthma Centers, P.C.
are mainly from our own practice.
The overwhelming number of patients
who do participate in research are
pleased with and appreciative of
the experience, but there are pros
and cons to involvement in clinical
trials. |
| |
Will
I benefit from participation?
Possible benefits include:
-
The
opportunity to contribute
to the development of medical
treatments for you and for
others.
-
Especially
close observation of your
allergies and asthma by experienced
staff. As a result more can
be learned about
-
Your
disease and how best to treat
and how to minimize any problems
from it for you, your child
and family, and your physician
-
All
drugs under study are provided
at no charge, and additional
medications and beneficial
medical tests may also be
provided
-
Monetary
compensation for your time,
efforts and travel expenses
On
the other hand, most studies have
a "placebo" possibility.
A placebo is a "dummy"
that contains no active medication
and is used to sort out a possible
treatment effect. We are all unaware
as to who might be selected at random
to be on placebo or active drug.
(This is called "double-blinded
randomized" selection as to
treatment.) Thus, neither the patient
nor our medical staff can predict
or select which patient gets active
study drug or placebo. However,
as a safety factor, all patients
are allowed a "back-up"
or "rescue" medication
to use as needed throughout the
study to treat symptoms that are
not controlled by the study drug
or placebo. Also, the medical appropriateness
of your participation in a specific
study is reviewed by the medical
staff at Colorado Allergy and Asthma
Centers, P.C. |
| |
How
long will the study last?
Most allergy studies will last approximately
3 weeks, while asthma studies typically
last approximately 3 months. However,
studies can last from 2 weeks to
1 or more years. The number of visits
and the length of time at each visit
are explained to you before you
decide whether or not you want to
participate. |
| |
How
long will the study last?
Most allergy studies will last approximately
3 weeks, while asthma studies typically
last approximately 3 months. However,
studies can last from 2 weeks to
1 or more years. The number of visits
and the length of time at each visit
are explained to you before you
decide whether or not you want to
participate.
As a volunteer, you have the right
to leave your study at any time
and for any reason, without compromising
of affecting your usual medical
care at Colorado Allergy and Asthma
Centers, P.C. |
| |
Will
locations and times be convenient?
Three of our offices have specifically
dedicated study staffs who work
along with our Colorado Allergy
and Asthma Centers physician investigators
in these offices. These offices
are often conveniently located near
work or home, and our extended hours
in the Study Department allow patients
to participate before work/school
or on Saturday. Currently clinical
trials are under way at each of
these offices. |
| |
How
do I participate?
Call any of these locations and
ask to speak to a study coordinator:
Denver
(Lowry) Office/Administrative Site
125 Rampart Way, Suite 150
(1 block east of Quebec Street and
First Avenue, on northeast corner)
Phone: (720) 858-7510
Fax: (720) 858-7530 Principal
Investigator:
David S. Pearlman, MD
Research
Site Manager:
Denise Curtis, RN, BSN, CCRC [ denisec@coloradoallergy.com
] Centennial
14000 East Arapahoe Road, Suite
260 Phone:
(303) 632-3646 Fax:
(303) 632-3611 Principal
Investigator: Leon
S. Greos, MD Research
Site Manager:
Stacy Wiseman, RN, CCRC [ stacyw@coloradoallergy.com
] Lakewood
1667 Cole Blvd., Building 19, Suite
205 Phone:
(303) 432-9707 Fax:
(303) 420-5974 Principal
Investigator: Grant
C. Olson, MD Research
Site Manager:
Gail Facciolo, CRTT, CETT, CCRC
[ gailf@coloradoallergy.com
]
What studies are currently enrolling?
Click
here for our current Clinical Studies. |